AI-powered generative agents could revolutionize public health policymaking. By fine-tuning these simulations, governments ...

Health and Human Services Secretary Robert F. Kennedy Jr. arrives before Ireland's Prime Minister Michel Martin and President ...

Yet vaccines using the new technology of mRNA were developed by Moderna and Pfizer/BioNTech in a matter of months, and were ...

HHS Secretary Robert F. Kennedy Jr. issued a “call to action” and sent vaccines after the death of a child with measles in ...

The United States Cutaneous Lymphoma Consortium is a multidisciplinary society of physicians which use collaborative research and education to improve the quality of life and prognosis of patients ...

Peptide-based vaccines deliver tumor-specific antigens to dendritic cells (DCs), triggering tumor-targeted T-cell responses. A peptide-peptide conjugate technology previously developed by researchers ...

Iowa lawmakers advanced a bill Monday banning the administration of mRNA vaccines. The bill, Senate File 360, would outlaw ...

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

As STAT’s Helen Branswell writes, mRNA vaccines are the fastest to make and the easiest to mass produce.

Ronald Moss, MD, FAAAAI, CEO of DIOSynVax, presented the data during the late-breaking session, highlighting the vaccine's ability to generate strong, broad neutralizing immune responses capable of ...

Manuel Elkin Patarroyo Murillo (Ataco, Tolima, Colombia, November 3, 1946 - Bogotá, January 9, 2025) was a Colombian immunologist and pathologist renowned for developing the first synthetic vaccine ...

U.S. health officials have expanded the recommended age range for people receiving the HPV vaccine to protect against several types of cancer to people in their mid-40s. MSK physicians offers advice ...